{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-07-10T23:08:59.459972+00:00","company":{"ticker":"SCNX","cik":1382574,"company_name":"Scienture Holdings, Inc."},"pagination":{"limit":100,"returned":72,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","counterparties":{"contract_counterparty":[{"display_name":"Superlatus, Inc.","detail":"merger","count":7,"first_seen":"2023-06-23T23:59:59+00:00","last_seen":"2024-01-11T23:59:59+00:00","evidence_fact_ids":[81756,126513,131505,134112,135791,135794,135795]},{"display_name":"Lafayette Energy Corp.","detail":"equity_purchase","count":1,"first_seen":"2024-03-06T23:59:59+00:00","last_seen":"2024-03-06T23:59:59+00:00","evidence_fact_ids":[69346]},{"display_name":"Micro Merchant Systems, Inc.","detail":"asset_purchase","count":1,"first_seen":"2024-02-16T23:59:59+00:00","last_seen":"2024-02-16T23:59:59+00:00","evidence_fact_ids":[74201]},{"display_name":"Perfect Day, Inc. and The Urgent Company, Inc.","detail":"asset_purchase","count":1,"first_seen":"2023-08-24T23:59:59+00:00","last_seen":"2023-08-24T23:59:59+00:00","evidence_fact_ids":[116824]},{"display_name":"Rainforest Distribution Corp","detail":"supply","count":1,"first_seen":"2023-10-13T23:59:59+00:00","last_seen":"2023-10-13T23:59:59+00:00","evidence_fact_ids":[106703]},{"display_name":"Superlatus Foods Inc.","detail":"asset_purchase","count":1,"first_seen":"2024-03-06T23:59:59+00:00","last_seen":"2024-03-06T23:59:59+00:00","evidence_fact_ids":[69347]},{"display_name":"Wood Sage, LLC","detail":"asset_purchase","count":1,"first_seen":"2023-01-23T23:59:59+00:00","last_seen":"2023-01-23T23:59:59+00:00","evidence_fact_ids":[184961]}],"lender":[{"display_name":"Streeterville Capital, LLC","detail":"loan","count":3,"first_seen":"2025-10-16T23:59:59+00:00","last_seen":"2026-05-01T23:59:59+00:00","evidence_fact_ids":[28942,28943,39578]}],"ma_counterparty":[{"display_name":"Micro Merchant Systems, Inc.","detail":"disposition","count":1,"first_seen":"2024-02-16T23:59:59+00:00","last_seen":"2024-02-16T23:59:59+00:00","evidence_fact_ids":[74202]},{"display_name":"Scienture, Inc.","detail":"acquisition","count":1,"first_seen":"2024-07-31T23:59:59+00:00","last_seen":"2024-07-31T23:59:59+00:00","evidence_fact_ids":[122597]},{"display_name":"Superlatus Foods Inc.","detail":"disposition","count":1,"first_seen":"2024-03-06T23:59:59+00:00","last_seen":"2024-03-06T23:59:59+00:00","evidence_fact_ids":[69352]},{"display_name":"Superlatus, Inc.","detail":"acquisition","count":1,"first_seen":"2023-07-31T23:59:59+00:00","last_seen":"2023-07-31T23:59:59+00:00","evidence_fact_ids":[126514]}]},"facts":[{"fact_type":"executive_change","fact_key":"1c63ff2432","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2026-05-29T21:00:24+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2026-05-26","interim":true,"role":"Interim Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Narasimhan Mani was appointed as Interim Chief Financial Officer at Scienture Holdings, Inc..","evidence_excerpt":"the Company appointed Dr. Narasimhan Mani (age 51) to serve as the Company’s Interim Chief Financial Officer (\"Interim CFO\") effective as of May 26, 2026.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001493152-26-026414","anchor_url":"https://secwatch.observer/filing/0001493152-26-026414#claim-1c63ff2432","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315226026414/0001493152-26-026414-index.htm"},{"fact_type":"executive_change","fact_key":"462181d1e3","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2026-05-29T21:00:24+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2026-05-26","interim":true,"role":"Chief Financial Officer","role_category":"cfo","successor_name":"Narasimhan Mani","successor_named":true},"claim":"Eric Sherb resigned as Chief Financial Officer at Scienture Holdings, Inc..","evidence_excerpt":"On May 26, 2026, Eric Sherb, the Chief Financial Officer (\"CFO\") of Scienture Holdings, Inc. (the \"Company\"), formally resigned his position as CFO and advised the Company that his resignation was due to personal reasons and not a result of any dispute or disagreement with the Company, its management, or its board of directors.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001493152-26-026414","anchor_url":"https://secwatch.observer/filing/0001493152-26-026414#claim-462181d1e3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315226026414/0001493152-26-026414-index.htm"},{"fact_type":"earnings_release","fact_key":"7322f1bea9873a4ff8d5adc1a4909df77cdff059","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2026-05-22T21:00:37+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"the three months ended March 31, 2026","report_date":"2026-05-18","result_type":"reported_results","revenue_text":"approximately $56 thousand"},"claim":"Scienture Holdings, Inc. reported the three months ended March 31, 2026 results: revenue approximately $56 thousand.","evidence_excerpt":"business\nupdate and reported financial results for the three months ended March 31, 2026. Q1\n2026 Financial Highlights Compared to Q1 2025: ● Revenue\n increased to approximately $56 thousand for the three months ended March 31, 2026, compared to approximately $10 thousand in the\n prior-year three-month period, representing an increase of approximately 449%","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-26-025062","anchor_url":"https://secwatch.observer/filing/0001493152-26-025062#claim-7322f1bea9873a4ff8d5adc1a4909df77cdff059","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315226025062/0001493152-26-025062-index.htm"},{"fact_type":"debt_financing","fact_key":"62912f39a5867a992c89d4bdf30142ad3ff0e37f","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2026-05-01T23:59:59+00:00","payload":{"counterparty":"Streeterville Capital, LLC","effective_date":"2026-04-27","event":"incurrence","instrument_type":"loan","interest_rate_text":"5% per annum","item_codes_triggered":["2.03"],"maturity_text":"eighteen months following the date of issuance","principal_text":"$3 million"},"claim":"Scienture Holdings, Inc. incurred loan of $3 million with Streeterville Capital, LLC at 5% per annum maturing eighteen months following the date of issuance.","evidence_excerpt":"On April 27, 2026, Scienture Holdings, Inc. (the “ Company ”) entered into and closed on a note purchase agreement (the “ Purchase Agreement ”) with Streeterville Capital, LLC, (the “ Lender ”) providing for the issuance of two secured promissory notes: (i) a Secured Promissory Note A-1 in the original principal amount of $8.42 million (the “ A-1 Note ”) and (ii) a Secured Promissory Note B in the original principal amount of $3 million (the “ B Note ”). The A-1 Note carries an original issue discount of $400,000 and the Company agreed to pay $20,000 to the Lender to cover the Lender’s transaction costs. The B Note does not carry an original issuance discount. At closing, the Lender paid $8 million to the Company and deposited an additional $3 million into an account at Lakeside Bank owned by the Company’s newly formed wholly-owned subsidiary, SCNX Holdings, LLC, a Utah limited liability company (“ SCNX Sub ”), to be held pursuant to a Deposit Account Control Agreement entered into amo","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001493152-26-020931","anchor_url":"https://secwatch.observer/filing/0001493152-26-020931#claim-62912f39a5867a992c89d4bdf30142ad3ff0e37f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315226020931/0001493152-26-020931-index.htm"},{"fact_type":"debt_financing","fact_key":"a89a540b0c42cd656f653316c58dc8065274efb4","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2026-05-01T23:59:59+00:00","payload":{"counterparty":"Streeterville Capital, LLC","effective_date":"2026-04-27","event":"incurrence","instrument_type":"loan","interest_rate_text":"9% per annum","item_codes_triggered":["2.03"],"maturity_text":"eighteen months following the date of issuance","principal_text":"$8.42 million"},"claim":"Scienture Holdings, Inc. incurred loan of $8.42 million with Streeterville Capital, LLC at 9% per annum maturing eighteen months following the date of issuance.","evidence_excerpt":"On April 27, 2026, Scienture Holdings, Inc. (the “ Company ”) entered into and closed on a note purchase agreement (the “ Purchase Agreement ”) with Streeterville Capital, LLC, (the “ Lender ”) providing for the issuance of two secured promissory notes: (i) a Secured Promissory Note A-1 in the original principal amount of $8.42 million (the “ A-1 Note ”) and (ii) a Secured Promissory Note B in the original principal amount of $3 million (the “ B Note ”). The A-1 Note carries an original issue discount of $400,000 and the Company agreed to pay $20,000 to the Lender to cover the Lender’s transaction costs. The B Note does not carry an original issuance discount. At closing, the Lender paid $8 million to the Company and deposited an additional $3 million into an account at Lakeside Bank owned by the Company’s newly formed wholly-owned subsidiary, SCNX Holdings, LLC, a Utah limited liability company (“ SCNX Sub ”), to be held pursuant to a Deposit Account Control Agreement entered into amo","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001493152-26-020931","anchor_url":"https://secwatch.observer/filing/0001493152-26-020931#claim-a89a540b0c42cd656f653316c58dc8065274efb4","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315226020931/0001493152-26-020931-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"5cdd65eb9bfa62b7da0c593708c5d3abc24ebfbe","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2025-10-17T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":null,"deficiency_type":"minimum_bid_price","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2025-10-14","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5450(a)(1)"],"rules_cited_in_text":true},"claim":"Scienture Holdings, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).","evidence_excerpt":"October 14, 2025, Scienture Holdings, Inc. (the “ Company ”) received a written notice from the Listing Qualifications\ndepartment of The Nasdaq Stock Market LLC (“ Nasdaq ”) indicating that the Company was not in compliance with\nNasdaq Listing Rule 5450(a)(1), as the minimum bid price of the Company’s common stock, par value $0.00001 (“ Common\nStock ”) had been below $1.00 per share for 30 consecutive business days (the “ Minimum Bid Price Requirement ”).\nAccording to that notice, the Company has 180 calendar days, or until April 13, 2026, to regain compliance with the Minimum Bid Price\nRequir","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-25-018505","anchor_url":"https://secwatch.observer/filing/0001493152-25-018505#claim-5cdd65eb9bfa62b7da0c593708c5d3abc24ebfbe","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315225018505/0001493152-25-018505-index.htm"},{"fact_type":"debt_financing","fact_key":"75cf8157aed386faa6ce3a30555fdc1a752c6598","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2025-10-16T23:59:59+00:00","payload":{"counterparty":"Streeterville Capital, LLC","effective_date":"2025-10-14","event":"incurrence","instrument_type":"senior_notes","interest_rate_text":"nine percent (9%) per annum","item_codes_triggered":["2.03"],"maturity_text":"seven months following the date of issuance","principal_text":"$3,911,111.11"},"claim":"Scienture Holdings, Inc. incurred senior notes of $3,911,111.11 with Streeterville Capital, LLC at nine percent (9%) per annum maturing seven months following the date of issuance.","evidence_excerpt":"On October 14, 2025, the Company entered into and closed on a note purchase agreement (the “ Purchase Agreement ”) with Streeterville Capital, LLC, (the “ Lender ”), which provided for the issuance of a senior secured promissory note in the principal amount of $3,911,111.11 (the “ Note ”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-25-018332","anchor_url":"https://secwatch.observer/filing/0001493152-25-018332#claim-75cf8157aed386faa6ce3a30555fdc1a752c6598","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315225018332/0001493152-25-018332-index.htm"},{"fact_type":"governance_change","fact_key":"7443baf85b8f91085b5c3a8a60330f0f3ef0c307","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2025-10-06T23:59:59+00:00","payload":{"change_type":"bylaw_amendment","effective_date":"2025-10-01","item_codes_triggered":["5.03"],"summary_text":"Amended Section 2.8 of the Bylaws to change stockholder meeting quorum requirement from a majority to one-third of voting stock."},"claim":"Scienture Holdings, Inc.: Amended Section 2.8 of the Bylaws to change stockholder meeting quorum requirement from a majority to one-third of voting stock (effective 2025-10-01).","evidence_excerpt":"On October 1, 2025, the board of directors of Scienture Holdings, Inc. (the “ Company ”) voted to amend Section 2.8 the Company’s Amended and Restated Bylaws (the “ Bylaws ”) to change the requirements for quorum at a meeting of the stockholders of the Company from a majority of voting stock to one-third of the voting stock (the “ Amendment ”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-25-017117","anchor_url":"https://secwatch.observer/filing/0001493152-25-017117#claim-7443baf85b8f91085b5c3a8a60330f0f3ef0c307","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315225017117/0001493152-25-017117-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"db42d9bf983fc7e54ba343dbe6bb3d993dd37177","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2025-05-22T23:59:59+00:00","payload":{"company_response":"believes it will be able to timely regain compliance","compliance_status":"deficient","cure_deadline":"2025-11-17","deficiency_type":"minimum_bid_price","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":false,"minimum_requirement":"$1.00","notice_date":"2025-05-19","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5450(a)(1)"],"rules_cited_in_text":true},"claim":"Scienture Holdings, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).","evidence_excerpt":"May 19, 2025, Scienture Holdings, Inc. (the “Company”) received a written notice from the Listing Qualifications department\nof The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5450(a)(1),\nas the minimum bid price of the Company’s common stock, par value $0.0001 (“Common Stock”) had been below $1.00 per\nshare for 30 consecutive business days (the “Minimum Bid Price Requirement”). According to that notice, the Company has 180\ncalendar days, or until November 17, 2025, to regain compliance with the Minimum Bid Price Requirement. To","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001641172-25-011945","anchor_url":"https://secwatch.observer/filing/0001641172-25-011945#claim-db42d9bf983fc7e54ba343dbe6bb3d993dd37177","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000164117225011945/0001641172-25-011945-index.htm"},{"fact_type":"executive_change","fact_key":"ddab9fa9f1","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2025-05-22T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-05-20","interim":false,"role":"Executive Chairman and co-Chief Executive Officer","role_category":"chair","successor_name":null,"successor_named":false},"claim":"Dr. Shankar Hariharan was appointed as Executive Chairman and co-Chief Executive Officer at Scienture Holdings, Inc..","evidence_excerpt":"The board of directors also appointed Dr. Mani to serve as a director on the Company’s board of directors to fill the vacancy created as a result of Mr. Ajjarapu’s resignation and appointed Dr. Hariharan to the position of Executive Chairman of the Company’s board of directors, each effective as of May 20, 2025.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001641172-25-011945","anchor_url":"https://secwatch.observer/filing/0001641172-25-011945#claim-ddab9fa9f1","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000164117225011945/0001641172-25-011945-index.htm"},{"fact_type":"executive_change","fact_key":"1c184a1fb5","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2025-05-22T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-05-20","interim":false,"role":"co-Chief Executive Officer, President and Director","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"Dr. Narasimhan Mani was appointed as co-Chief Executive Officer, President and Director at Scienture Holdings, Inc..","evidence_excerpt":"the Company’s board of directors appointed Dr. Narasimhan Mani, age 50, and Dr. Shankar Hariharan, age 68, to serve as co-Chief Executive Officers of the Company effective as of May 20, 2025.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001641172-25-011945","anchor_url":"https://secwatch.observer/filing/0001641172-25-011945#claim-1c184a1fb5","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000164117225011945/0001641172-25-011945-index.htm"},{"fact_type":"executive_change","fact_key":"445f1b93d2","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2025-05-22T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2025-05-20","interim":false,"role":"President and Chief Operating Officer","role_category":"coo","successor_name":"Dr. Narasimhan Mani","successor_named":true},"claim":"Prashant Patel resigned as President and Chief Operating Officer at Scienture Holdings, Inc..","evidence_excerpt":"As part of the planned leadership transition, Prashant Patel also advised the Company that he was resigning from his position as the Company’s President and Chief Operating Officer, effective as of May 20, 2025.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001641172-25-011945","anchor_url":"https://secwatch.observer/filing/0001641172-25-011945#claim-445f1b93d2","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000164117225011945/0001641172-25-011945-index.htm"},{"fact_type":"executive_change","fact_key":"13462436f6","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2025-05-22T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2025-05-16","interim":false,"role":"Chief Executive Officer and Chairman of the Board","role_category":"ceo","successor_name":"Dr. Narasimhan Mani, Dr. Shankar Hariharan","successor_named":true},"claim":"Suren Ajjarapu resigned as Chief Executive Officer and Chairman of the Board at Scienture Holdings, Inc..","evidence_excerpt":"On May 16, 2025, as part of a planned leadership succession, Suren Ajjarapu advised the Company that he was resigning from his position as the Company’s Chief Executive Officer and Chairman of the Board effective immediately.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001641172-25-011945","anchor_url":"https://secwatch.observer/filing/0001641172-25-011945#claim-13462436f6","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000164117225011945/0001641172-25-011945-index.htm"},{"fact_type":"executive_change","fact_key":"661e90b8af","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2025-03-13T23:59:59+00:00","payload":{"action":"resigned","action_category":"role_change","departure_tone":"routine","effective_date":"2025-03-13","interim":true,"role":"Interim Principal Financial/Accounting Officer","role_category":"cfo","successor_name":"Eric Sherb","successor_named":true},"claim":"Prashant Patel resigned as Interim Principal Financial/Accounting Officer at Scienture Holdings, Inc..","evidence_excerpt":"Mr. Patel notified the Company’s Board of Directors of his intention to resign his position as Interim Principal Financial/Accounting Officer effective as of the Effective Date.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-25-010215","anchor_url":"https://secwatch.observer/filing/0001493152-25-010215#claim-661e90b8af","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315225010215/0001493152-25-010215-index.htm"},{"fact_type":"executive_change","fact_key":"cc1e24379c","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2025-03-13T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-03-13","interim":false,"role":"Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Eric Sherb was appointed as Chief Financial Officer at Scienture Holdings, Inc..","evidence_excerpt":"On March 13, 2025, the Board of Directors of Scienture Holdings, Inc. (the “Company”) appointed Eric Sherb to serve as the Company’s Chief Financial Officer effective as of March 13, 2025","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-25-010215","anchor_url":"https://secwatch.observer/filing/0001493152-25-010215#claim-cc1e24379c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315225010215/0001493152-25-010215-index.htm"},{"fact_type":"executive_change","fact_key":"e1d9135554","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2025-01-17T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2025-01-16","interim":false,"role":"director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Prashant Patel resigned as director at Scienture Holdings, Inc..","evidence_excerpt":"On January 15, 2025 and January 16, respectively, Narasimhan Mani and Prashant Patel each voluntarily resigned as directors of Scienture Holdings, Inc.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-25-002749","anchor_url":"https://secwatch.observer/filing/0001493152-25-002749#claim-e1d9135554","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315225002749/0001493152-25-002749-index.htm"},{"fact_type":"executive_change","fact_key":"45ad54745b","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2025-01-17T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2025-01-15","interim":false,"role":"director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Narasimhan Mani resigned as director at Scienture Holdings, Inc..","evidence_excerpt":"On January 15, 2025 and January 16, respectively, Narasimhan Mani and Prashant Patel each voluntarily resigned as directors of Scienture Holdings, Inc.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-25-002749","anchor_url":"https://secwatch.observer/filing/0001493152-25-002749#claim-45ad54745b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315225002749/0001493152-25-002749-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"5850f1501e81abc3bd8cdcd1799e9eac1ab90e5a","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2025-01-08T23:59:59+00:00","payload":{"company_response":"Company intends to hold an annual meeting as soon as practicable and will file proxy statement.","compliance_status":"deficient","cure_deadline":null,"deficiency_type":"shareholders","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":false,"minimum_requirement":null,"notice_date":"2025-01-03","notice_type":"deficiency_notice","plan_due_date":"2025-02-18","raw_rule_text":null,"reported_value":null,"rule_numbers":["5620(a)"],"rules_cited_in_text":true},"claim":"Scienture Holdings, Inc. received a nasdaq deficiency notice notice regarding shareholders (rules 5620(a)).","evidence_excerpt":"January 3, 2025, Scienture Holdings, Inc. (the “Company”) received a written notice from the Listing Qualifications department\nof The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5620(a),\ndue to the Company not holding an annual meeting of stockholders in 2024 within one year of the Company’s 2023 fiscal year end.\nThe Company has until February 18, 2025, which is 45 days from the date of the notice, to submit a plan to regain compliance and, if\nNasdaq accepts the plan, it may grant up to 180 calendar days from the fiscal year end","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-25-001429","anchor_url":"https://secwatch.observer/filing/0001493152-25-001429#claim-5850f1501e81abc3bd8cdcd1799e9eac1ab90e5a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315225001429/0001493152-25-001429-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"a27b48f37fd88e5f9a546b393fa18f0e1a8bc268","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2025-01-08T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":null,"deficiency_type":"other","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":false,"minimum_requirement":null,"notice_date":"2025-01-03","notice_type":"deficiency_notice","plan_due_date":"2025-02-18","raw_rule_text":null,"reported_value":null,"rule_numbers":["5620(a)"]},"claim":"Scienture Holdings, Inc. received a nasdaq deficiency notice notice regarding other (rules 5620(a)).","evidence_excerpt":"January 3, 2025, Scienture Holdings, Inc. (the “Company”) received a written notice from the Listing Qualifications department\nof The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance w","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-25-001429","anchor_url":"https://secwatch.observer/filing/0001493152-25-001429#claim-a27b48f37fd88e5f9a546b393fa18f0e1a8bc268","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315225001429/0001493152-25-001429-index.htm"},{"fact_type":"ma_transaction","fact_key":"1f0f534b668a218600fd8c07a352c1c488387748","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2024-07-31T23:59:59+00:00","payload":{"action":"acquisition","closing_date":"2024-07-25","consideration_text":null,"counterparty":"Scienture, Inc.","effective_date":"2024-07-25","item_codes_triggered":["2.01"]},"claim":"Scienture Holdings, Inc. completed an acquisition involving Scienture, Inc. (closed 2024-07-25).","evidence_excerpt":"The parties consummated the Mergers on July 25, 2024.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-029787","anchor_url":"https://secwatch.observer/filing/0001493152-24-029787#claim-1f0f534b668a218600fd8c07a352c1c488387748","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315224029787/0001493152-24-029787-index.htm"},{"fact_type":"executive_change","fact_key":"6ddc4edde8","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2024-07-31T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-07-25","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Narasimhan Mani was appointed as Director at Scienture Holdings, Inc..","evidence_excerpt":"on July 25, 2024, the Company’s Board appointed Shankar Hariharan and Narasimhan Mani to the Board.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-029787","anchor_url":"https://secwatch.observer/filing/0001493152-24-029787#claim-6ddc4edde8","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315224029787/0001493152-24-029787-index.htm"},{"fact_type":"executive_change","fact_key":"2da7fe9992","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2024-07-31T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-07-25","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Shankar Hariharan was appointed as Director at Scienture Holdings, Inc..","evidence_excerpt":"on July 25, 2024, the Company’s Board appointed Shankar Hariharan and Narasimhan Mani to the Board.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-029787","anchor_url":"https://secwatch.observer/filing/0001493152-24-029787#claim-2da7fe9992","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315224029787/0001493152-24-029787-index.htm"},{"fact_type":"executive_change","fact_key":"5110df3ae4","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2024-06-20T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-06-17","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Narasimhan Mani resigned as Director at Scienture Holdings, Inc..","evidence_excerpt":"On June 17, 2024, Narasimhan Mani voluntarily resigned as a director of the Company.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-024424","anchor_url":"https://secwatch.observer/filing/0001493152-24-024424#claim-5110df3ae4","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315224024424/0001493152-24-024424-index.htm"},{"fact_type":"executive_change","fact_key":"47c21bf6d8","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2024-06-20T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-06-17","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Subbarao Jayanthi was appointed as Director at Scienture Holdings, Inc..","evidence_excerpt":"On June 17, 2024, the board of directors (the “Board”) of TRxADE Health, Inc. (the “Company”) appointed Subbarao Jayanthi to the Board.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-024424","anchor_url":"https://secwatch.observer/filing/0001493152-24-024424#claim-47c21bf6d8","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315224024424/0001493152-24-024424-index.htm"},{"fact_type":"executive_change","fact_key":"abf94e0ba8","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2024-05-30T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-05-30","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Michael L. Peterson resigned as Director at Scienture Holdings, Inc..","evidence_excerpt":"On May 30, 2024, Jeff Newell and Michael L. Peterson each voluntarily resigned as a directors of the Company.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-021967","anchor_url":"https://secwatch.observer/filing/0001493152-24-021967#claim-abf94e0ba8","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315224021967/0001493152-24-021967-index.htm"},{"fact_type":"executive_change","fact_key":"5271fc7a3b","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2024-05-30T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-05-30","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Jeff Newell resigned as Director at Scienture Holdings, Inc..","evidence_excerpt":"On May 30, 2024, Jeff Newell and Michael L. Peterson each voluntarily resigned as a directors of the Company.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-021967","anchor_url":"https://secwatch.observer/filing/0001493152-24-021967#claim-5271fc7a3b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315224021967/0001493152-24-021967-index.htm"},{"fact_type":"executive_change","fact_key":"8fe42e9191","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2024-05-30T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-05-28","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Narasimhan Mani was appointed as Director at Scienture Holdings, Inc..","evidence_excerpt":"On May 28, 2024, the Company’s board of directors (the “Board”) appointed Mayur Doshi and Narasimhan Mani to the Board.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-021967","anchor_url":"https://secwatch.observer/filing/0001493152-24-021967#claim-8fe42e9191","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315224021967/0001493152-24-021967-index.htm"},{"fact_type":"executive_change","fact_key":"c079dcc290","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2024-05-30T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-05-28","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Mayur Doshi was appointed as Director at Scienture Holdings, Inc..","evidence_excerpt":"On May 28, 2024, the Company’s board of directors (the “Board”) appointed Mayur Doshi and Narasimhan Mani to the Board.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-021967","anchor_url":"https://secwatch.observer/filing/0001493152-24-021967#claim-c079dcc290","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315224021967/0001493152-24-021967-index.htm"},{"fact_type":"ma_transaction","fact_key":"58e45969a313761c7661ca739fc275a50fef5e76","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2024-03-06T23:59:59+00:00","payload":{"action":"disposition","closing_date":"2024-03-05","consideration_text":"$1.00","counterparty":"Superlatus Foods Inc.","effective_date":"2024-03-05","item_codes_triggered":["2.01"]},"claim":"Scienture Holdings, Inc. completed a disposition involving Superlatus Foods Inc. for $1.00 (closed 2024-03-05).","evidence_excerpt":"arch 5, 2024, the Company entered in a Stock Purchase Agreement (“SPA”) with Superlatus Foods Inc. (the “Buyer”).\nPursuant to the SPA, the Company sold all of the issued and outstanding stock (the “Stock”) of Superlatus Inc., a Delaware","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-24-008947","anchor_url":"https://secwatch.observer/filing/0001493152-24-008947#claim-58e45969a313761c7661ca739fc275a50fef5e76","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315224008947/0001493152-24-008947-index.htm"},{"fact_type":"material_agreement","fact_key":"4d83c7541df0429b18d2146f76d77f96112b5675","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2024-03-06T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Stock Purchase Agreement","agreement_type":"asset_purchase","counterparty":"Superlatus Foods Inc.","effective_date":"2024-03-05","item_codes_triggered":["1.01"],"value_text":"$1.00"},"claim":"Scienture Holdings, Inc. entered into Stock Purchase Agreement with Superlatus Foods Inc. valued at $1.00 (effective 2024-03-05).","evidence_excerpt":"On March 5, 2024, the Company entered in a Stock Purchase Agreement (“SPA”) with Superlatus Foods Inc. (the “Buyer”). Pursuant to the SPA, the Company sold all of the issued and outstanding stock (the “Stock”) of Superlatus Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“Superlatus”), to the Buyer. The purchase price for the Stock was $1.00","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-24-008947","anchor_url":"https://secwatch.observer/filing/0001493152-24-008947#claim-4d83c7541df0429b18d2146f76d77f96112b5675","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315224008947/0001493152-24-008947-index.htm"},{"fact_type":"material_agreement","fact_key":"428910b8c624911fe1db66f261c92113de6da0b4","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2024-03-06T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Subscription Agreement","agreement_type":"equity_purchase","counterparty":"Lafayette Energy Corp.","effective_date":"2024-02-29","item_codes_triggered":["1.01"],"value_text":"up to $5.0 million"},"claim":"Scienture Holdings, Inc. entered into Subscription Agreement with Lafayette Energy Corp. valued at up to $5.0 million (effective 2024-02-29).","evidence_excerpt":"On February 29, 2024, the Company’s wholly owned subsidiary Trxade, Inc. entered into a Subscription Agreement (the “Subscription Agreement”) with Lafayette Energy Corp., a Delaware corporation (“Lafayette”). Pursuant to the Subscription Agreement, Trxade, Inc. will, in two equal tranches, invest a total of up to $5.0 million in Lafayette in exchange for up to 2,000,000 shares of Lafayette’s newly created Series A Convertible Preferred Stock","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-24-008947","anchor_url":"https://secwatch.observer/filing/0001493152-24-008947#claim-428910b8c624911fe1db66f261c92113de6da0b4","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315224008947/0001493152-24-008947-index.htm"},{"fact_type":"ma_transaction","fact_key":"b431918d3219f9f61d857cdc52602480ca114947","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2024-02-16T23:59:59+00:00","payload":{"action":"disposition","closing_date":"2024-02-16","consideration_text":"$22.5 million","counterparty":"Micro Merchant Systems, Inc.","effective_date":"2024-02-16","item_codes_triggered":["2.01"]},"claim":"Scienture Holdings, Inc. completed a disposition involving Micro Merchant Systems, Inc. for $22.5 million (closed 2024-02-16).","evidence_excerpt":"continue to own its assets that are unrelated to the web-based market platform operated by Trxade, Inc. The\npurchase price under the Purchase Agreement to be paid at closing is $22.5 million, subject to customary adjustments for cash, indebtedness,\nworking capital and transaction expenses. Subject to the terms and conditions of the Purchase Agreement, if, during the","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-24-007038","anchor_url":"https://secwatch.observer/filing/0001493152-24-007038#claim-b431918d3219f9f61d857cdc52602480ca114947","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315224007038/0001493152-24-007038-index.htm"},{"fact_type":"material_agreement","fact_key":"4ad65f9958ebebef75c1ace4f970dc33f7f7096f","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2024-02-16T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Purchase Agreement","agreement_type":"asset_purchase","counterparty":"Micro Merchant Systems, Inc.","effective_date":"2024-02-16","item_codes_triggered":["1.01"],"value_text":"$22.5 million"},"claim":"Scienture Holdings, Inc. entered into Purchase Agreement with Micro Merchant Systems, Inc. valued at $22.5 million (effective 2024-02-16).","evidence_excerpt":"TRxADE HEALTH Inc. (the “Company”) together with Trxade, Inc., a wholly owned subsidiary of the Company, and Micro Merchant Systems, Inc. (“MMS”) entered into an asset purchase agreement on February 16, 2024 (the “Purchase Agreement”) under which MMS agreed to purchase for cash substantially all of the assets of Trxade, Inc.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-24-007038","anchor_url":"https://secwatch.observer/filing/0001493152-24-007038#claim-4ad65f9958ebebef75c1ace4f970dc33f7f7096f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315224007038/0001493152-24-007038-index.htm"},{"fact_type":"material_agreement","fact_key":"1f5c175ff8a17d326f746eccbfff6e892d397c55","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2024-01-11T23:59:59+00:00","payload":{"action":"amendment","agreement_name":"Amended and Restated Agreement and Plan of Merger","agreement_type":"merger","counterparty":"Superlatus, Inc.","effective_date":"2024-01-08","item_codes_triggered":["1.01"],"value_text":"Company Equity Value adjusted to 12,500,000; Merger Consideration adjusted to 1,712,328 shares of co"},"claim":"Scienture Holdings, Inc. amended Amended and Restated Agreement and Plan of Merger with Superlatus, Inc. valued at Company Equity Value adjusted to 12,500,000; Merger Consideration adjusted to 1,712,328 shares of co (effective 2024-01-08).","evidence_excerpt":"As previously reported on a Current Report on Form 8-K filed on July 31, 2023 TRxADE HEALTH, Inc., a Delaware corporation (the “Company”), completed its acquisition of Superlatus, Inc., (“Superlatus”) and Foods Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”) in accordance with the terms and conditions of the Amended and Restated Agreement and Plan of Merger (the “Merger Agreement”), pursuant to which the Company acquired Superlatus by way of a merger of the Merger Sub with and into Superlatus, with Superlatus being a wholly owned subsidiary of the Company and the surviving entity in the merger (“Merger”). Superlatus was not able to meet the post-closing condition of acquiring Prestige Farms, Inc. and on January 8, 2024, the Company entered into an amendment agreement to the Merger Agreement with Superlatus and Merger Sub (the “Amendment”).","confidence":0.99,"filing_url":"https://secwatch.observer/filing/0001493152-24-002099","anchor_url":"https://secwatch.observer/filing/0001493152-24-002099#claim-1f5c175ff8a17d326f746eccbfff6e892d397c55","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315224002099/0001493152-24-002099-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"280fddae9c5be35abd00c2046aceafdf0a95fb2c","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2023-11-28T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"plan_due","cure_deadline":null,"deficiency_type":"late_filing","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2023-11-21","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5250(c)(1)"],"rules_cited_in_text":true},"claim":"Scienture Holdings, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).","evidence_excerpt":"November 21, 2023, the Company received a notice (the “Notice”) from the Nasdaq Listing Qualifications Department (“Nasdaq”)\nindicating that the Company is not compliant with the timely filing requirement for continued listing under Nasdaq Listing Rule 5250(c)(1)\n(the “Listing Rule”), which requires listed companies to timely file all required periodic reports with the SEC. The\nNotice will have no immediate effect on the listing or trading of the Company’s common stock, although there can be no assurances\nthat further delays in the filing of the Form 10-Q will not have an impact on the listing","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-23-042872","anchor_url":"https://secwatch.observer/filing/0001493152-23-042872#claim-280fddae9c5be35abd00c2046aceafdf0a95fb2c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223042872/0001493152-23-042872-index.htm"},{"fact_type":"material_agreement","fact_key":"9d3779bfc059a49177c02c9d1758b4f82ef9ef85","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2023-10-13T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Supplier Agreement","agreement_type":"supply","counterparty":"Rainforest Distribution Corp","effective_date":"2023-10-09","item_codes_triggered":["1.01"],"value_text":null},"claim":"Scienture Holdings, Inc. entered into Supplier Agreement with Rainforest Distribution Corp (effective 2023-10-09).","evidence_excerpt":"On October 9, 2023 (the “Effective Date”), Superlatus PD Holding Company (“Superlatus”), a Delaware corporation and wholly owned subsidiary of Superlatus, Inc. (a wholly owned subsidiary of TRxADE HEALTH, Inc.), entered into a supplier agreement (the “Supplier Agreement”) with Rainforest Distribution Corp, a New York corporation (“Rainforest”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-037138","anchor_url":"https://secwatch.observer/filing/0001493152-23-037138#claim-9d3779bfc059a49177c02c9d1758b4f82ef9ef85","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223037138/0001493152-23-037138-index.htm"},{"fact_type":"governance_change","fact_key":"5279e6e3f0886cd260cd9fd5e27020433a33e4e9","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2023-10-11T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2023-10-04","item_codes_triggered":["5.03"],"summary_text":"Filed Certificate of Designation establishing Series C Preferred Stock with 1,000 authorized shares, $1,000 stated value per share, including dividend, voting, liquidation, conversion, and redemption terms."},"claim":"Scienture Holdings, Inc.: Filed Certificate of Designation establishing Series C Preferred Stock with 1,000 authorized shares, $1,000 stated value per share, including dividend, voting, liquidation, conversion, and redemption terms (effective 2023-10-04).","evidence_excerpt":"On October 4, 2023 (the “ Filing Date ”), the Company filed the Certificate of Designation with the Secretary of State of the State of Delaware designating 1,000 shares out of the authorized but unissued shares of its preferred stock as Series C Preferred Stock with a stated value of $1,000 per share.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-23-036917","anchor_url":"https://secwatch.observer/filing/0001493152-23-036917#claim-5279e6e3f0886cd260cd9fd5e27020433a33e4e9","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223036917/0001493152-23-036917-index.htm"},{"fact_type":"auditor_change","fact_key":"6203358e4e19e76f08465aecf6893ef1602947be","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2023-09-14T23:59:59+00:00","payload":{"action":"engagement","auditor_name":"CM3 Advisory","disagreement_text":null,"effective_date":"2023-09-14","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":null},"claim":"Scienture Holdings, Inc. engaged CM3 Advisory as its auditor.","evidence_excerpt":"ngagement of CM3 Advisory On\nSeptember 14, 2023, the Company engaged CM3 Advisory (“CM3”) as its new independent registered public accounting firm of","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-032673","anchor_url":"https://secwatch.observer/filing/0001493152-23-032673#claim-6203358e4e19e76f08465aecf6893ef1602947be","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223032673/0001493152-23-032673-index.htm"},{"fact_type":"auditor_change","fact_key":"791298cb8b848866c3972c52987e664b12d43706","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2023-09-14T23:59:59+00:00","payload":{"action":"dismissal","auditor_name":"MaloneBailey, LLP","disagreement_text":null,"effective_date":"2023-09-14","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":"CM3 Advisory"},"claim":"Scienture Holdings, Inc. dismissed MaloneBailey, LLP as its auditor.","evidence_excerpt":"ismissal of MaloneBailey, LLP On\nSeptember 14, 2023, TRxADE HEALTH, Inc. (the “Company” or “MEDS”) dismissed MaloneBailey, LLP (“MaloneBailey”)\nas its independent registered public accounting firm to audit the Company’s financial statements, to be effective immediately.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-032673","anchor_url":"https://secwatch.observer/filing/0001493152-23-032673#claim-791298cb8b848866c3972c52987e664b12d43706","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223032673/0001493152-23-032673-index.htm"},{"fact_type":"material_agreement","fact_key":"8c12ce237d389eba8f8087ddab59827a485d85cc","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2023-08-24T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Asset Purchase Agreement","agreement_type":"asset_purchase","counterparty":"Perfect Day, Inc. and The Urgent Company, Inc.","effective_date":"2023-08-21","item_codes_triggered":["1.01"],"value_text":"$1,250,000"},"claim":"Scienture Holdings, Inc. entered into Asset Purchase Agreement with Perfect Day, Inc. and The Urgent Company, Inc. valued at $1,250,000 (effective 2023-08-21).","evidence_excerpt":"On August 21, 2023 (the \"Effective Date\"), Superlatus, Inc., a Delaware corporation and wholly owned subsidiary of TRxADE HEALTH, Inc. (\"Superlatus\"), entered into an Asset Purchase Agreement (the \"Asset Purchase Agreement\") with Perfect Day, Inc., a Delaware corporation (\"PD\") and The Urgent Company, Inc., a Delaware corporation (\"TUC\" and together with PD, collectively, \"Sellers\").","confidence":0.99,"filing_url":"https://secwatch.observer/filing/0001493152-23-030055","anchor_url":"https://secwatch.observer/filing/0001493152-23-030055#claim-8c12ce237d389eba8f8087ddab59827a485d85cc","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223030055/0001493152-23-030055-index.htm"},{"fact_type":"ma_transaction","fact_key":"803b63bfb52d601f5ac5e9548dc8ef54feee6272","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2023-07-31T23:59:59+00:00","payload":{"action":"acquisition","closing_date":"2023-07-31","consideration_text":"136,441 shares of common stock of the Company, representing 19.9% of the total issued and outstanding common stock of the Company after the consummation of the","counterparty":"Superlatus, Inc.","effective_date":"2023-07-31","item_codes_triggered":["2.01","5.01"]},"claim":"Scienture Holdings, Inc. completed an acquisition involving Superlatus, Inc. for 136,441 shares of common stock of the Company, representing 19.9% of the total issued and outstanding common stock of the Company after the consummation of the (closed 2023-07-31).","evidence_excerpt":"the surviving entity\nin the Merger. Under\nthe terms of the A&R Merger Agreement, at the closing of the Merger (the “Closing”), shareholders of Superlatus received\nin aggregate 136,441 shares of common stock of the Company, representing 19.9% of the total issued and outstanding common stock of the\nCompany after the consummation of the Merger and 306,855 shares","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-026024","anchor_url":"https://secwatch.observer/filing/0001493152-23-026024#claim-803b63bfb52d601f5ac5e9548dc8ef54feee6272","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223026024/0001493152-23-026024-index.htm"},{"fact_type":"material_agreement","fact_key":"61c30b183664f9090b9cd86387394a470c995c8b","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2023-07-31T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Amended and Restated Agreement and Plan of Merger","agreement_type":"merger","counterparty":"Superlatus, Inc.","effective_date":"2023-07-14","item_codes_triggered":["1.01"],"value_text":"136,441 shares of common stock ... and 306,855 shares of Company's Series B Preferred Stock"},"claim":"Scienture Holdings, Inc. entered into Amended and Restated Agreement and Plan of Merger with Superlatus, Inc. valued at 136,441 shares of common stock ... and 306,855 shares of Company's Series B Preferred Stock (effective 2023-07-14).","evidence_excerpt":"on July 14, 2023, TRxADE HEALTH, Inc., a Delaware corporation (the \"Company\" or \"MEDS\") entered into a certain Amended and Restated Agreement and Plan of Merger (the \"A&R Merger Agreement\") with Superlatus, Inc., a U.S.-based holding company of food products and distribution capabilities (\"Superlatus\") and Foods Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of the Company (\"Merger Sub\").","confidence":0.87,"filing_url":"https://secwatch.observer/filing/0001493152-23-026024","anchor_url":"https://secwatch.observer/filing/0001493152-23-026024#claim-61c30b183664f9090b9cd86387394a470c995c8b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223026024/0001493152-23-026024-index.htm"},{"fact_type":"material_agreement","fact_key":"762e42ee1faad75a61c9d9b4fc513f60a03e11ed","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2023-07-14T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Amended and Restated Agreement and Plan of Merger","agreement_type":"merger","counterparty":"Superlatus, Inc.","effective_date":"2023-07-14","item_codes_triggered":["1.01"],"value_text":"30,821,941 shares of Company stock at $7.30 per share, comprised of 136,441 shares of common stock ("},"claim":"Scienture Holdings, Inc. entered into Amended and Restated Agreement and Plan of Merger with Superlatus, Inc. valued at 30,821,941 shares of Company stock at $7.30 per share, comprised of 136,441 shares of common stock ( (effective 2023-07-14).","evidence_excerpt":"As previously disclosed, on June 30, 2023, TRxADE HEALTH, Inc., a Delaware corporation (the “Company” or “MEDS”), entered into an Agreement and Plan of Merger (the “Original Merger Agreement”) with Superlatus, Inc., a U.S.-based holding company of food products and distribution capabilities (“Superlatus”). On July 14, 2023, the Company and Superlatus entered into an Amended and Restated Agreement and Plan of Merger (the “A&R Merger Agreement”; the transactions contemplated thereby, the “Merger”), which amends the merger consideration payable to the shareholders of Superlatus and adds the issuance of non-transferrable rights to receive shares of common stock of the Company at no cost to the shareholders of the Company in connection with the Merger.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-23-024613","anchor_url":"https://secwatch.observer/filing/0001493152-23-024613#claim-762e42ee1faad75a61c9d9b4fc513f60a03e11ed","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223024613/0001493152-23-024613-index.htm"},{"fact_type":"material_agreement","fact_key":"22779dadf28afe270a1ffd5c4564c73f92a3575d","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2023-06-30T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Agreement and Plan of Merger","agreement_type":"merger","counterparty":"Superlatus Inc.","effective_date":"2023-06-30","item_codes_triggered":["1.01"],"value_text":null},"claim":"Scienture Holdings, Inc. entered into Agreement and Plan of Merger with Superlatus Inc. (effective 2023-06-30).","evidence_excerpt":"On June 30, 2023, TRxADE Health, Inc., a Delaware corporation (the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) by and among the Company, Superlatus Inc., a Delaware corporation (“Superlatus”), and Foods Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-023016","anchor_url":"https://secwatch.observer/filing/0001493152-23-023016#claim-22779dadf28afe270a1ffd5c4564c73f92a3575d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223023016/0001493152-23-023016-index.htm"},{"fact_type":"governance_change","fact_key":"8ca209c5b58dac96a6362063671bad396fdc29f5","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2023-06-26T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2023-06-26","item_codes_triggered":["5.03"],"summary_text":"Filed Certificate of Designation for Series B Preferred Stock, setting forth terms including non-participating, no dividends, no liquidation preference, no voting rights, no redemption rights, and conversion upon stockholder approval into 100 shares of common stock each."},"claim":"Scienture Holdings, Inc.: Filed Certificate of Designation for Series B Preferred Stock, setting forth terms including non-participating, no dividends, no liquidation preference, no voting rights, no redemption rights, and conversion upon stockholder approval into 100 shares of common stock each (effective 2023-06-26).","evidence_excerpt":"On June 26, 2023, the Company filed a Certificate of Designation, Preferences, Rights and Limitations of the Series B Preferred Stock with the Secretary of State of the State of Delaware (the “Certificate of Designation”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-022532","anchor_url":"https://secwatch.observer/filing/0001493152-23-022532#claim-8ca209c5b58dac96a6362063671bad396fdc29f5","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223022532/0001493152-23-022532-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"ee9f045b7df7a7f7dc56386ab56ee2e74afa818d","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2023-06-26T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":null,"deficiency_type":"other","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":"500,000 publicly held shares","notice_date":"2023-06-23","notice_type":"deficiency_notice","plan_due_date":"2023-08-07","raw_rule_text":"Listing Rule 5550(a)(4)","reported_value":"approximately 310,057","rule_numbers":["5550(a)(4)"],"rules_cited_in_text":true},"claim":"Scienture Holdings, Inc. received a nasdaq deficiency notice notice regarding other (rules 5550(a)(4)).","evidence_excerpt":"June 23, 2023, the Listing Qualifications department of The Nasdaq Stock Market LLC (the “Nasdaq”) notified the Company that\nthe Company was not in compliance with Nasdaq’s listing rules (the “Listing Rules”) as set forth in Listing Rule 5550(a)(4)\ngiven the Company’s failure to maintain a sufficient number of publicly held shares (the “Notice”). Citing the Company’s\nEvent Form submitted to Nasdaq on June 7, 2023, Nasdaq calculated the Company’s publicly held shares as approximately 310,057 (which\namount excludes shares held by officers, directors, or beneficial owners of 10 percent or more)","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-022532","anchor_url":"https://secwatch.observer/filing/0001493152-23-022532#claim-ee9f045b7df7a7f7dc56386ab56ee2e74afa818d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223022532/0001493152-23-022532-index.htm"},{"fact_type":"material_agreement","fact_key":"47f31b2d072c577d158264d3c2d50434baed96b3","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2023-06-23T23:59:59+00:00","payload":{"action":"amendment","agreement_name":"Amendment to Acquisition Letter","agreement_type":"merger","counterparty":"Superlatus, Inc.","effective_date":"2023-06-23","item_codes_triggered":["1.01"],"value_text":"Amendment to correct the number of shares to be received by Superlatus shareholders upon closing of"},"claim":"Scienture Holdings, Inc. amended Amendment to Acquisition Letter with Superlatus, Inc. valued at Amendment to correct the number of shares to be received by Superlatus shareholders upon closing of (effective 2023-06-23).","evidence_excerpt":"On June 23, 2023, the Company and Superlatus entered into an amendment (the “Amendment to Acquisition Letter”) to the LOI to correct the number of shares to be received by Superlatus shareholders upon closing of the Merger.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-23-022283","anchor_url":"https://secwatch.observer/filing/0001493152-23-022283#claim-47f31b2d072c577d158264d3c2d50434baed96b3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223022283/0001493152-23-022283-index.htm"},{"fact_type":"material_agreement","fact_key":"b2e57f24788474f18fb0f71c9508b441602f75c3","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2023-06-23T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Binding Letter of Intent for Merger","agreement_type":"merger","counterparty":"Superlatus, Inc.","effective_date":"2023-06-22","item_codes_triggered":["1.01"],"value_text":"3,839,176 shares of the Company, valued at $58.61 per share, comprised of common stock (19.99% of to"},"claim":"Scienture Holdings, Inc. entered into Binding Letter of Intent for Merger with Superlatus, Inc. valued at 3,839,176 shares of the Company, valued at $58.61 per share, comprised of common stock (19.99% of to (effective 2023-06-22).","evidence_excerpt":"On June 22, 2023, TRxADE HEALTH, Inc. (the “Company”) entered into a binding letter of intent (“LOI”) for a merger (the “Merger”) with Superlatus, Inc., a U.S.-based holding company of food products and distribution capabilities (“Superlatus”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-23-022283","anchor_url":"https://secwatch.observer/filing/0001493152-23-022283#claim-b2e57f24788474f18fb0f71c9508b441602f75c3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223022283/0001493152-23-022283-index.htm"},{"fact_type":"material_agreement","fact_key":"73c88d77509928cfaacd7ceae85a823d5b62d067","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2023-06-23T23:59:59+00:00","payload":{"action":"entry","agreement_name":"LOI","agreement_type":"merger","counterparty":"Superlatus, Inc.","effective_date":"2023-06-22","item_codes_triggered":["1.01"],"value_text":null},"claim":"Scienture Holdings, Inc. entered into LOI with Superlatus, Inc. (effective 2023-06-22).","evidence_excerpt":"On June 22, 2023, TRxADE HEALTH, INC. (the \"Company\") entered into a binding letter of intent (\"LOI\") for a merger (the \"Merger\") with Superlatus, Inc., a U.S.-based holding company of food products and distribution capabilities (\"Superlatus\").","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-022184","anchor_url":"https://secwatch.observer/filing/0001493152-23-022184#claim-73c88d77509928cfaacd7ceae85a823d5b62d067","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223022184/0001493152-23-022184-index.htm"},{"fact_type":"governance_change","fact_key":"352a744e0df5fed10361215bcb840c91fb148c28","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2023-06-15T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":null,"item_codes_triggered":["5.03"],"summary_text":"Stockholders authorized the Board to amend and restate Article V, Subsection 3 of the Second Amended and Restated Certificate of Incorporation to effect a reverse stock split at a ratio ranging from one-for-ten to one-for-hundred, at the Board's discretion, by December 31, 2023."},"claim":"Scienture Holdings, Inc.: Stockholders authorized the Board to amend and restate Article V, Subsection 3 of the Second Amended and Restated Certificate of Incorporation to effect a reverse stock split at a ratio ranging from one-for-ten to one-for-hundred, at the Board's discretion, by December 31, 2023.","evidence_excerpt":"The stockholders of the Company authorized the Board of Directors of the Company in its sole and absolute discretion, and without further action of the stockholders, to file a Certificate of Amendment at the 2023 Annual Meeting, which amends and restates subsection 3 of Article V ( Reverse Stock Split of Outstanding Common Stock ) to effect a reverse split of the Company’s issued and outstanding common stock, par value $0.00001 per share, at a ratio to be determined by the Board, ranging from one-for-ten to one-for-one hundred","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-021489","anchor_url":"https://secwatch.observer/filing/0001493152-23-021489#claim-352a744e0df5fed10361215bcb840c91fb148c28","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223021489/0001493152-23-021489-index.htm"},{"fact_type":"shareholder_vote","fact_key":"e8d2f3882a54439c39446e17749ae5fd436529f7","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2023-06-15T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-06-15","outcome":"passed","proposal_text":"Ratification of Appointment of MaloneBailey LLP as Independent Auditor","proposal_type":"auditor_ratification","results":[{"broker_non_votes":"0","subject":null,"votes_abstain":"73,600","votes_against":"1,673","votes_for":"5,341,101","votes_withheld":null}]},"claim":"Scienture Holdings, Inc. shareholders approved Ratification of Appointment of MaloneBailey LLP as Independent Auditor at the 2023-06-15 meeting.","evidence_excerpt":"Proposal 4—Ratification of Appointment of MaloneBailey LLP as Independent Auditor The Company's stockholders approved a proposal to ratify the appointment of MaloneBailey LLP as our independent auditor for the fiscal year ending December 31, 2023. The following votes were taken in connection with this proposal: FOR AGAINST ABSTAIN BROKER NON-VOTE Number % Number % Number % Number % 5,341,101 52.31 1,673 0.02 73,600 0.72 0 0","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-021489","anchor_url":"https://secwatch.observer/filing/0001493152-23-021489#claim-e8d2f3882a54439c39446e17749ae5fd436529f7","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223021489/0001493152-23-021489-index.htm"},{"fact_type":"shareholder_vote","fact_key":"199b156da4aae599ec75df956e7f371c692c0f3d","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2023-06-15T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-06-15","outcome":"passed","proposal_text":"Election of Directors","proposal_type":"director_election","results":[{"broker_non_votes":null,"subject":"Suren Ajjarapu","votes_abstain":null,"votes_against":null,"votes_for":"5,411,101","votes_withheld":"5,273"},{"broker_non_votes":null,"subject":"Prashant Patel","votes_abstain":null,"votes_against":null,"votes_for":"5,404,997","votes_withheld":"11,377"},{"broker_non_votes":null,"subject":"Donald G. Fell","votes_abstain":null,"votes_against":null,"votes_for":"5,349,507","votes_withheld":"66,867"},{"broker_non_votes":null,"subject":"Michael L. Peterson","votes_abstain":null,"votes_against":null,"votes_for":"5,411,191","votes_withheld":"28,438"},{"broker_non_votes":null,"subject":"Jeff Newell","votes_abstain":null,"votes_against":null,"votes_for":"5,411,191","votes_withheld":"5,273"}]},"claim":"Scienture Holdings, Inc. shareholders approved Election of Directors at the 2023-06-15 meeting.","evidence_excerpt":"Proposal 3—Election of Directors The following individuals, constituting all of the nominees named in the Proxy Statement, were elected as directors","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-021489","anchor_url":"https://secwatch.observer/filing/0001493152-23-021489#claim-199b156da4aae599ec75df956e7f371c692c0f3d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223021489/0001493152-23-021489-index.htm"},{"fact_type":"shareholder_vote","fact_key":"fcde5f4f37f6dfd93c4e4e6e7ca423bc89104765","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2023-06-15T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-06-15","outcome":"passed","proposal_text":"Amendment of the Second Amended and Restated 2019 Equity Incentive Plan","proposal_type":"equity_plan","results":[{"broker_non_votes":"0","subject":null,"votes_abstain":"0","votes_against":"142,621","votes_for":"5,273,753","votes_withheld":null}]},"claim":"Scienture Holdings, Inc. shareholders approved Amendment of the Second Amended and Restated 2019 Equity Incentive Plan at the 2023-06-15 meeting.","evidence_excerpt":"Proposal 2—Amendment of the Second Amended and Restated 2019 Equity Incentive Plan The Company's stockholders approved a proposal to amend the Company's Second Amended and Restated 2019 Equity Incentive Plan to increase the number of shares reserved for issuance thereunder by 2,000,000 shares. The following votes were taken in connection with this proposal: FOR AGAINST ABSTAIN BROKER NON-VOTE Number % Number % Number % Number % 5,273,753 51.65 142, 621 1.40 0 0 0 0","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-021489","anchor_url":"https://secwatch.observer/filing/0001493152-23-021489#claim-fcde5f4f37f6dfd93c4e4e6e7ca423bc89104765","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223021489/0001493152-23-021489-index.htm"},{"fact_type":"shareholder_vote","fact_key":"68082070cfb113bf6d38bb2e6a01b3219941dce7","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2023-06-15T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-06-15","outcome":"passed","proposal_text":"Reverse Stock Split","proposal_type":"reverse_split","results":[{"broker_non_votes":"0","subject":null,"votes_abstain":"0","votes_against":"88,393","votes_for":"5,327,981","votes_withheld":null}]},"claim":"Scienture Holdings, Inc. shareholders approved Reverse Stock Split at the 2023-06-15 meeting.","evidence_excerpt":"The following votes were taken in connection with this proposal: FOR AGAINST ABSTAIN BROKER NON-VOTE Number % Number % Number % Number % 5,327,981 52.18 88,393 0.87 0 0 0 0","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-021489","anchor_url":"https://secwatch.observer/filing/0001493152-23-021489#claim-68082070cfb113bf6d38bb2e6a01b3219941dce7","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223021489/0001493152-23-021489-index.htm"},{"fact_type":"earnings_release","fact_key":"775e4a8df8b7736da8daee62a3d97a2833d42031","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2023-05-15T23:59:59+00:00","payload":{"eps_text":"($0.07) per basic and diluted share","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"($0.7) million","period_text":"the quarter ended March 31, 2023","report_date":"2023-05-15","result_type":"reported_results","revenue_text":"$2.2 million"},"claim":"Scienture Holdings, Inc. reported the quarter ended March 31, 2023 results: revenue $2.2 million, net income ($0.7) million, EPS ($0.07) per basic and diluted share.","evidence_excerpt":"First Quarter 2023 Financial Summary Consolidated revenues for the first quarter of 2023 compared to the first quarter of 2022 decreased 31% to $2.2 million, compared to $3.2 million, respectively. The decrease in consolidated revenue was driven by decreased revenue attributed to our Trxade Prime subsidiary. The revenues generated by the TRxADE Platform in the first quarter of 2023 compared to 2022 increased 4% and Trxade Prime year over year revenue declined 70% in 2023 compared to 2022. The subsidiary company Community Specialty Pharmacy experienced a 16% increase in revenue for the first quarter 2023 compared to 2022. Gross profit analysis of comparable fiscal periods of 2023 and 2022 reflect an increase in gross profits of $221,000 for the first quarter of 2023 compared to 2022. As a percent of revenue, consolidated gross profit increased to 69% for the comparable quarter periods of 2023 and 2022. Operating expenses for the first quarter of 2023 were $1.9 million, compared to $2.3","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-017359","anchor_url":"https://secwatch.observer/filing/0001493152-23-017359#claim-775e4a8df8b7736da8daee62a3d97a2833d42031","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223017359/0001493152-23-017359-index.htm"},{"fact_type":"earnings_release","fact_key":"b798b3dcd44e1fa0c2ad86cf09e0dc640b674bfc","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2023-03-27T23:59:59+00:00","payload":{"eps_text":"($0.41) per basic and diluted share outstanding","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"($3.9) million","period_text":"the year ended December 31, 2022","report_date":"2023-03-27","result_type":"reported_results","revenue_text":"$11.4 million"},"claim":"Scienture Holdings, Inc. reported the year ended December 31, 2022 results: revenue $11.4 million, net income ($3.9) million, EPS ($0.41) per basic and diluted share outstanding.","evidence_excerpt":"Consolidated revenues for the fiscal year of 2022 compared to the fiscal year of 2021 increased 16% to $11.4 million, compared to $9.9 million, respectively. The increase in consolidated revenue was driven by improved revenue attributed to our TRxADE Platform and Trxade Prime subsidiaries. The revenues generated by the TRxADE Platform in the fiscal year 2022 compared to 2021 increased 10% and Trxade Prime year over year revenue improved 46% in 2022 compared to 2021. The subsidiary company Community Specialty Pharmacy experienced a 29% decrease in revenue for the fiscal year 2022 compared to 2021. Gross profit analysis of comparable fiscal periods of 2022 and 2021 reflect an increase in gross profits of $0.7 million for the fiscal year of 2022 compared to 2021. As a percent of revenue, consolidated gross profit remained consistent at 48% for the comparable annual periods of 2022 and 2021. Operating expenses for the fiscal year of 2022 were $9.9 million, compared to $10 million in the fi","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-23-009089","anchor_url":"https://secwatch.observer/filing/0001493152-23-009089#claim-b798b3dcd44e1fa0c2ad86cf09e0dc640b674bfc","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223009089/0001493152-23-009089-index.htm"},{"fact_type":"executive_change","fact_key":"e7a88c4e07","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2023-03-06T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2023-03-06","interim":true,"role":"Interim Principal Financial/Accounting Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Prashant Patel was appointed as Interim Principal Financial/Accounting Officer at Scienture Holdings, Inc..","evidence_excerpt":"Also effective on March 6, 2023, Prashant Patel, a member of the Board of Directors, the President and the Chief Operating Officer of the Company, was appointed as Interim Principal Financial/Accounting Officer of the Company.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-23-006779","anchor_url":"https://secwatch.observer/filing/0001493152-23-006779#claim-e7a88c4e07","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223006779/0001493152-23-006779-index.htm"},{"fact_type":"executive_change","fact_key":"432276ecda","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2023-03-06T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2023-03-06","interim":true,"role":"Acting Chief Financial Officer and Principal Financial/Accounting Officer","role_category":"cfo","successor_name":"Prashant Patel","successor_named":true},"claim":"Janet Huffman resigned as Acting Chief Financial Officer and Principal Financial/Accounting Officer at Scienture Holdings, Inc..","evidence_excerpt":"On March 6, 2023, Ms. Huffman resigned as Acting Chief Financial Officer and Principal Financial/Accounting Officer of the Company in order to transition to a full-time role with another employer","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-23-006779","anchor_url":"https://secwatch.observer/filing/0001493152-23-006779#claim-432276ecda","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223006779/0001493152-23-006779-index.htm"},{"fact_type":"executive_change","fact_key":"cf23975bd4","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2023-03-03T23:59:59+00:00","payload":{"action":"transitioned","action_category":"role_change","departure_tone":"not_applicable","effective_date":"2023-03-01","interim":true,"role":"Acting Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Janet Huffman changed role as Acting Chief Financial Officer at Scienture Holdings, Inc..","evidence_excerpt":"Effective March 1, 2023, Ms. Huffman also transitioned from Chief Financial Officer to Acting Chief Financial Officer, but is remaining with the Company in that role and is continuing to serve as Principal Financial/Accounting Officer of the Company.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-23-006678","anchor_url":"https://secwatch.observer/filing/0001493152-23-006678#claim-cf23975bd4","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223006678/0001493152-23-006678-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"2b4ccb1d979f7994068b6953af160e53900e4e3f","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2023-02-07T23:59:59+00:00","payload":{"company_response":"submitted a hearing request","compliance_status":"hearing_requested","cure_deadline":null,"deficiency_type":"stockholders_equity","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":"2023-02-06","immediate_listing_effect":null,"minimum_requirement":"$2,500,000","notice_date":"2023-02-06","notice_type":"delisting_notice","plan_due_date":null,"raw_rule_text":"minimum $2,500,000 stockholders' equity requirement set forth in Nasdaq Listing Rule 550(b)","reported_value":null,"rule_numbers":[],"rules_cited_in_text":false},"claim":"Scienture Holdings, Inc. received a nasdaq delisting notice notice regarding stockholders equity.","evidence_excerpt":"February 6, 2023, the Company submitted a hearing request to the Nasdaq Hearings Panel (the “ Panel ”), which request\nwill stay any delisting action by the Staff at least until the hearing process concludes and any extension granted by the Panel expires. At\nthe Panel hearing, the Company intends to present a plan to regain compliance with the minimum stockholders’ equity requirement.\nIn the interim, the Company’s common stock will continue to trade on Nasdaq under the symbol “ MEDS ” at least\npending the ultimate conclusion of the hearing process. There\ncan be no assurance that the Company’s p","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-23-003740","anchor_url":"https://secwatch.observer/filing/0001493152-23-003740#claim-2b4ccb1d979f7994068b6953af160e53900e4e3f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223003740/0001493152-23-003740-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"38876caab585cae44e6d487144758898aae14885","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2023-02-01T23:59:59+00:00","payload":{"company_response":"intends to submit a hearing request to the Nasdaq Hearings Panel","compliance_status":"delisting_pending","cure_deadline":"2023-01-25","deficiency_type":"stockholders_equity","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":"pending","immediate_listing_effect":null,"minimum_requirement":"$2,500,000 stockholders' equity","notice_date":"2023-01-30","notice_type":"delisting_notice","plan_due_date":null,"raw_rule_text":"Nasdaq Listing Rule 5550(b)","reported_value":null,"rule_numbers":["5550(b)"],"rules_cited_in_text":true},"claim":"Scienture Holdings, Inc. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)).","evidence_excerpt":"January 30, 2023, the Company received a delist determination letter from the Staff advising the Company that the Staff had determined\nthat the Company did not meet the terms of the extension. Specifically, the Company did not complete its proposed transactions and was\nunable to file a Current Report Form 8-K by the January 25, 2023 deadline previously required by the Staff, evidencing compliance with\nthe Rule. As a result, unless the Company requests an appeal of the Staff’s determination,\ntrading of the Company’s common stock will be suspended at the opening of business on February 8, 2023","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-003204","anchor_url":"https://secwatch.observer/filing/0001493152-23-003204#claim-38876caab585cae44e6d487144758898aae14885","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223003204/0001493152-23-003204-index.htm"},{"fact_type":"material_agreement","fact_key":"dd1fe27172b02d88f9ddb74585b3fcbf7a893297","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2023-01-23T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Membership Interest Purchase Agreements (Alliance Sale Agreement and CSP Sale Agreement)","agreement_type":"asset_purchase","counterparty":"Wood Sage, LLC","effective_date":"2023-01-20","item_codes_triggered":["1.01"],"value_text":"Total consideration of $125,000 (Alliance) + $100,000 (CSP) + approximately $266,000 due under Maste"},"claim":"Scienture Holdings, Inc. entered into Membership Interest Purchase Agreements (Alliance Sale Agreement and CSP Sale Agreement) with Wood Sage, LLC valued at Total consideration of $125,000 (Alliance) + $100,000 (CSP) + approximately $266,000 due under Maste (effective 2023-01-20).","evidence_excerpt":"On January 20, 2023, TRxADE HEALTH, Inc. (the “ Company ”, “ we ”, or “ us ”), entered into: (1) a Membership Interest Purchase Agreement with Wood Sage, LLC (“ Wood Sage ”), and the Company’s wholly-owned subsidiary, Alliance Pharma Solutions, LLC (“ Alliance ” and the “ Alliance Sale Agreement ”); and (2) a Membership Interest Purchase Agreement with Wood Sage and the Company’s wholly-owned subsidiary, Community Specialty Pharmacy, LLC (“ CSP ” and the “ CSP Sale Agreement ”, and together with the Alliance Sale Agreement, the “ Sale Agreements ”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-23-002126","anchor_url":"https://secwatch.observer/filing/0001493152-23-002126#claim-dd1fe27172b02d88f9ddb74585b3fcbf7a893297","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223002126/0001493152-23-002126-index.htm"},{"fact_type":"executive_change","fact_key":"e02ae94e45","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2023-01-05T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2023-01-04","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Michael L. Peterson was appointed as Director at Scienture Holdings, Inc..","evidence_excerpt":"On January 4, 2023, the Board of Directors of the Company, with the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors, appointed Mr. Michael L. Peterson as a member of the Board of Directors, with such appointment to take effect immediately, to fill the vacancy left by Mr. Pope’s resignation.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-23-000662","anchor_url":"https://secwatch.observer/filing/0001493152-23-000662#claim-e02ae94e45","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223000662/0001493152-23-000662-index.htm"},{"fact_type":"executive_change","fact_key":"3037943e16","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2023-01-05T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2023-01-03","interim":false,"role":"Director","role_category":"director","successor_name":"Michael L. Peterson","successor_named":true},"claim":"Charles L. Pope resigned as Director at Scienture Holdings, Inc..","evidence_excerpt":"On January 3, 2023, Charles L. Pope resigned as a member of the Board of Directors of TRxADE HEALTH, INC.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-23-000662","anchor_url":"https://secwatch.observer/filing/0001493152-23-000662#claim-3037943e16","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223000662/0001493152-23-000662-index.htm"},{"fact_type":"shareholder_vote","fact_key":"8145b52a0045ea14cde7d25888122c17287a7efd","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2022-12-21T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2022-12-20","outcome":"passed","proposal_text":"Adjournment of Special Meeting if necessary to solicit additional proxies","proposal_type":"other","results":[{"broker_non_votes":"0","subject":null,"votes_abstain":"2,700","votes_against":"48,893","votes_for":"5,519,397","votes_withheld":null}]},"claim":"Scienture Holdings, Inc. shareholders approved Adjournment of Special Meeting if necessary to solicit additional proxies at the 2022-12-20 meeting.","evidence_excerpt":"2. Proposal No. 2: To approve an adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the proposal to approve the Warrant Share Issuance Proposal: For Against Abstentions Broker Non-Votes 5,519,397 48,893 2,700 0","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-22-036149","anchor_url":"https://secwatch.observer/filing/0001493152-22-036149#claim-8145b52a0045ea14cde7d25888122c17287a7efd","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315222036149/0001493152-22-036149-index.htm"},{"fact_type":"shareholder_vote","fact_key":"07d3d2092d70f0113f97d56fe3ac6bb8962fb314","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2022-12-21T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2022-12-20","outcome":"passed","proposal_text":"Approval of issuance of up to 2,663,045 shares of common stock upon exercise of Private Placement Warrants","proposal_type":"other","results":[{"broker_non_votes":"0","subject":null,"votes_abstain":"2,640","votes_against":"11,610","votes_for":"5,557,740","votes_withheld":null}]},"claim":"Scienture Holdings, Inc. shareholders approved Approval of issuance of up to 2,663,045 shares of common stock upon exercise of Private Placement Warrants at the 2022-12-20 meeting.","evidence_excerpt":"1. Proposal No. 1: To approve the issuance of up to 2,663,045 shares of our common stock upon exercise of an outstanding common stock purchase warrant (the “ Private Placement Warrants ”), in accordance with the Nasdaq Listing Rules (the “ Warrant Share Issuance Proposal ”): For Against Abstentions Broker Non-Votes 5,557,740 11,610 2,640 0 Proposal No. 1 was approved by approximately 99.7% of the aggregate total of shares of common stock voted at the Special Meeting, and as such Proposal No. 1 was approved by the stockholders.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-22-036149","anchor_url":"https://secwatch.observer/filing/0001493152-22-036149#claim-07d3d2092d70f0113f97d56fe3ac6bb8962fb314","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315222036149/0001493152-22-036149-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"04032ff54cdda1208e3e9072d81f5c53c8559365","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2022-12-01T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":"2023-05-29","deficiency_type":"minimum_bid_price","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":"$1.00 per share","notice_date":"2022-11-29","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":"minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2)","reported_value":null,"rule_numbers":["5550(a)(2)"],"rules_cited_in_text":true},"claim":"Scienture Holdings, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).","evidence_excerpt":"November 29, 2022, TRxADE HEALTH, Inc. (the “ Company ”, “ we ” or “ us ”) received\nwritten notice (the “ Notification Letter ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC\n(“ Nasdaq ”) notifying the Company that it is not in compliance with the minimum bid price requirements set forth in\nNasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities\nto maintain a minimum bid price of $1.00 per share, and Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price\nre","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-22-034200","anchor_url":"https://secwatch.observer/filing/0001493152-22-034200#claim-04032ff54cdda1208e3e9072d81f5c53c8559365","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315222034200/0001493152-22-034200-index.htm"},{"fact_type":"earnings_release","fact_key":"a919b9b5081e5ea45da8b9acaaac74bab60e8968","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2022-11-07T23:59:59+00:00","payload":{"eps_text":"($0.06) per basic and diluted share","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"($0.5) million","period_text":"for the three and nine months ended September 30, 2022","report_date":"2022-11-07","result_type":"reported_results","revenue_text":"$2.4 million"},"claim":"Scienture Holdings, Inc. reported for the three and nine months ended September 30, 2022 results: revenue $2.4 million, net income ($0.5) million, EPS ($0.06) per basic and diluted share.","evidence_excerpt":"growth opportunities.” Third\nQuarter 2022 Financial Summary Consolidated\nrevenues for the third quarter of 2022 compared to the third quarter of 2021, decreased 6% to $2.4 million, compared to $2.6 million,\nrespectively. The consolidated decrease in revenue, is driven by decreases in revenue attributed to our TRxADE Prime and Community Specialty\nPharmacy","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-22-030831","anchor_url":"https://secwatch.observer/filing/0001493152-22-030831#claim-a919b9b5081e5ea45da8b9acaaac74bab60e8968","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315222030831/0001493152-22-030831-index.htm"},{"fact_type":"executive_change","fact_key":"56010ef7b1","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2022-10-03T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2022-09-30","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Jeff Newell was appointed as Director at Scienture Holdings, Inc..","evidence_excerpt":"On September 30, 2022, the Board of Directors of TRxADE HEALTH, INC. (“ TRxADE ”, the “ Company ”, “ we ” and “ us ”), with the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors, appointed Mr. Jeff Newell as a member of the Board of Directors, with such appointment to take effect immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-22-027358","anchor_url":"https://secwatch.observer/filing/0001493152-22-027358#claim-56010ef7b1","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315222027358/0001493152-22-027358-index.htm"},{"fact_type":"executive_change","fact_key":"be40cc485c","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2022-09-01T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2022-08-26","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Christine L. Jennings resigned as Director at Scienture Holdings, Inc..","evidence_excerpt":"On August 26, 2022, Christine L. Jennings resigned as a member of the Board of Directors of TRxADE HEALTH, INC.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-22-024846","anchor_url":"https://secwatch.observer/filing/0001493152-22-024846#claim-be40cc485c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315222024846/0001493152-22-024846-index.htm"},{"fact_type":"executive_change","fact_key":"9f9f939621","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2022-04-01T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2022-04-02","interim":false,"role":"Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Janet Huffman was appointed as Chief Financial Officer at Scienture Holdings, Inc..","evidence_excerpt":"On March 31, 2022, the Board of Directors approved the appointment of Ms. Janet Huffman, the Company’s Director of Finance (a non-executive position), as CFO and Principal Financial/Accounting Officer of the Company, effective April 2, 2022, upon effectiveness of Mr. Doss’ resignation.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-22-008842","anchor_url":"https://secwatch.observer/filing/0001493152-22-008842#claim-9f9f939621","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315222008842/0001493152-22-008842-index.htm"},{"fact_type":"executive_change","fact_key":"eab667492c","cik":1382574,"ticker":"SCNX","company_name":"Scienture Holdings, Inc.","filed_at":"2022-04-01T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2022-04-02","interim":false,"role":"Chief Financial Officer","role_category":"cfo","successor_name":"Janet Huffman","successor_named":true},"claim":"Howard A. Doss resigned as Chief Financial Officer at Scienture Holdings, Inc..","evidence_excerpt":"Mr. Doss who has been employed as CFO since January 2014, is resigning to spend time with his family and pursue other business opportunities.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-22-008842","anchor_url":"https://secwatch.observer/filing/0001493152-22-008842#claim-eab667492c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315222008842/0001493152-22-008842-index.htm"}]}